157 related articles for article (PubMed ID: 31745730)
21. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
22. The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis.
Xu XL; Chen SZ; Chen W; Zheng WH; Xia XH; Yang HJ; Li B; Mao WM
Breast Cancer Res Treat; 2013 Jun; 139(2):329-39. PubMed ID: 23670132
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis.
Sridhar S; Rajesh C; Jishnu PV; Jayaram P; Kabekkodu SP
Breast Cancer Res Treat; 2020 Jan; 179(2):301-313. PubMed ID: 31664550
[TBL] [Abstract][Full Text] [Related]
24. Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis.
Wang J; Yin J; Yang Q; Ding F; Chen X; Li B; Tian X
Oncotarget; 2016 Nov; 7(47):76693-76703. PubMed ID: 27736797
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of FOXA1 in breast cancer: A systematic review and meta-analysis.
Shou J; Lai Y; Xu J; Huang J
Breast; 2016 Jun; 27():35-43. PubMed ID: 27212698
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis.
Huang W; Ran R; Shao B; Li H
Breast Cancer Res Treat; 2019 Nov; 178(1):17-33. PubMed ID: 31359214
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
29. NRF2 immunolocalization in human breast cancer patients as a prognostic factor.
Onodera Y; Motohashi H; Takagi K; Miki Y; Shibahara Y; Watanabe M; Ishida T; Hirakawa H; Sasano H; Yamamoto M; Suzuki T
Endocr Relat Cancer; 2014 Apr; 21(2):241-52. PubMed ID: 24302665
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis.
Miao C; Liang C; Zhu J; Xu A; Zhao K; Hua Y; Zhang J; Chen W; Suo C; Zhang C; Liu Y; Su S; Wang Z
Oncotarget; 2017 May; 8(19):32309-32321. PubMed ID: 28427222
[TBL] [Abstract][Full Text] [Related]
31. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.
Zhang HS; Du GY; Zhang ZG; Zhou Z; Sun HL; Yu XY; Shi YT; Xiong DN; Li H; Huang YH
Int J Biochem Cell Biol; 2018 Feb; 95():85-92. PubMed ID: 29275212
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis reveals no significant correlation between breast cancer survival and ErbB3 expression.
Kim HJ; Kim A; Ahn H; Ahn IM; Choi J; Chang H
APMIS; 2015 May; 123(5):383-93. PubMed ID: 25912128
[TBL] [Abstract][Full Text] [Related]
34. Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
Mazzotta A; Partipilo G; De Summa S; Giotta F; Simone G; Mangia A
Tumour Biol; 2016 May; 37(5):6143-53. PubMed ID: 26614429
[TBL] [Abstract][Full Text] [Related]
35. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of survivin in breast cancer: meta-analysis.
Li Y; Ma X; Wu X; Liu X; Liu L
Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
[TBL] [Abstract][Full Text] [Related]
37. Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Ahn C; Jeong CW; Kwak C; Kim HH; Kim HS; Ku JH
Clin Genitourin Cancer; 2018 Aug; 16(4):e831-e841. PubMed ID: 29551582
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
[TBL] [Abstract][Full Text] [Related]
39. Correlation of Nrf2 and HIF-1α in glioblastoma and their relationships to clinicopathologic features and survival.
Ji X; Wang H; Zhu J; Tang Y; Zhou Y; Zhu L; Gao C; Li W; You W; Yu B; Xia Q
Neurol Res; 2013 Dec; 35(10):1044-50. PubMed ID: 24070025
[TBL] [Abstract][Full Text] [Related]
40. Expression of PD-L1 and prognosis in breast cancer: a meta-analysis.
Zhang M; Sun H; Zhao S; Wang Y; Pu H; Wang Y; Zhang Q
Oncotarget; 2017 May; 8(19):31347-31354. PubMed ID: 28430626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]